Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children Outpatients (PUL NIS)

AstraZeneca

Status: Completed

Conditions: Cough Variant Asthma

Study type: Observational

Funder types: Industry

Identifiers

NCT00660114

NIS-RCN-PUL-2008/1

Details and patient eligibility

About

This open label, non-interventional study is to show the efficacy of Pulmicort®Respules® in cough variant asthma in patient aged 5-year old or younger in outpatient department

Enrollment: 914 patients

Sex: All

Ages: Under 5 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Provision of informed consent
• Patient who has been prescribed Pulmicort® Respules® according to physician's judgement, irrespective of the inclusion in the study.
• The usage of Pulmicort® Respules® follows local authorised package insert.

Exclusion criteria

• Allergy to any ingredient of Pulmicort® Respules®
• With history of Leukotriene Modifier (LM) usage prior to 2 weeks of recruitment or following plan.
• Have used systemic/inhaled steroid prior to 2 weeks of recruitment